Kenneth D. Chi, MD Medical Director, GI Lab Advocate Lutheran General Hospital Center for Digestive Health May 7, 2016

Size: px
Start display at page:

Download "Kenneth D. Chi, MD Medical Director, GI Lab Advocate Lutheran General Hospital Center for Digestive Health May 7, 2016"

Transcription

1 Kenneth D. Chi, MD Medical Director, GI Lab Advocate Lutheran General Hospital Center for Digestive Health May 7, 2016

2 Why have Quality Indicators? Pre-procedure Quality Indicators Intra-procedure Quality Indicators Post-procedure Quality Indicators What does this mean to us and how we practice?

3 >3.3 Million colonoscopies are done/yr USA ½ are done for screening and surveillence (2010 Data)

4 Transition of screening colonoscopy from a fee-for-service model to a Quality-based model Impact of these performance data on reimbursement rates from both CMS and third-party payers

5 Purpose of Quality Indicators 1. To reduce the frequency of missed colon cancers post colonoscopy 2. To minimize the risk to patients and to maximize the cost-effectiveness of CRC screening by minimizing the overuse of repeated colonoscopy

6 1. 100% adherence to each QI is not expected Cecal intubation (target is 95%, not 100%) 2. These QI are being implemented by CMS as well as many insurers as numeric targets that they expect endoscopists to report Our payments are going to be tied to our ability to report and to achieve high quality in our ability to meet certain numeric indicators

7 Documentation issues Informed consent is documented in > 98% Quality of bowel prep is documented in > 98% Withdrawal time is documented in >98% Appropriate Indication for Colonoscopy is documented in the report in >80% of patients Based on when they had their last colonoscopy Based on what their last pathology was <to reduce the frequency of inappropriate colonoscopy>

8 1. You should be able to get to the cecum > 95% of patients* You should have photodocumentation of the appendiceal orifice and the IC valve *If prep is poor (aborted) does NOT count towards calculation 2. Bowel Prep Documentation & Adequacy 3. Adenoma detection rate* *Priority Indicator

9 Bowel prep should be documented in >98% of the time Bowel prep should be Adequate 85% of the time New recommendations state there are only 2 options: 1. Adequate 2. Inadequate (unable to see polyps >5mm) Repeat colonoscopy in 1 YEAR suboptimal Can I bring patient back in 5 years? not really. This is not a rationale that is consistent with known data about missed colon cancers Doesn t take into account the fact that we are doing this to hopefully catch a missed adenoma before it actually turns into a colon cancer BUT this is not consistent with what we know about Missed Colon Cancers as the mean time to diagnosis of missed colon cancer are identified in only 3.5 years.

10 How do you calculate the ADR? Denominator = Total # patients who are at average risk getting a Screening colonoscopy Numerator = # of people where you find at least 1 adenoma Might be Simplistic : but fewer than 25% practices are reporting ADRs (survey data) 2006 Target ADR was 20% Now increased to 25% The reason is there is more data now the higher the ADR is, the less likely patients are found to have a missed colon cancer There was a 3% reduction in CRC incidence and 5% reduction in cancer mortality for each 1% increase in ADR

11

12

13

14

15 Document appropriate followup interval for their next colonoscopy in at least 90% patients* Normal = recommend Repeat 10 years 1 adenoma = recommend Repeat in 5 years We need to document the histology in some type of database and report to minimize overuse Perforations should be < 1:1000 Post-polypectomy bleeding should be <1% *Priority Indicator

16 As of 2015, all GIs are required to report the Quality Indicators through the physician quality reporting system (PQRS) CMS Requirements are being accepted by GIQuIC (ASGE/ACG benchmarking program) Our government is 2 years behind: In 2017 CMS will look at 2015 data to see how we did: 2% penalty if unable to hit these targets 2% additional penalty in reimbursement from CMS if GIs fail to report

17 Much has changed in how gastroenterologists perform colonoscopies from 10 years ago All colonoscopies are truly not created equal, but with these Quality Measures being imposed on us, we are trying to ensure good quality colonoscopies for our patients

18 Began March 1, 2016 Currently enrolled 102 patients 13 patients have been scheduled, and 8 procedures completed 27 patients did not meet criteria

Digestive Health Southwest Endoscopy 2016 Quality Report

Digestive Health Southwest Endoscopy 2016 Quality Report Digestive Health 2016 Quality Report Our 2016 our quality and value management program focused on one primary area of interest: Performing high quality colonoscopy High quality Colonoscopy We selected

More information

Colonoscopy Quality Data

Colonoscopy Quality Data Colonoscopy Quality Data www.dhsgi.com Introduction Colorectal cancer is the second leading cause of cancer related deaths in the United States, in men and women combined. In 2016, there are expected to

More information

11/9/2015 OUTLINE. Quality Indicators for the Doctor Performing Screening Colonoscopy: What you should expect from your Endoscopist

11/9/2015 OUTLINE. Quality Indicators for the Doctor Performing Screening Colonoscopy: What you should expect from your Endoscopist Quality Indicators for the Doctor Performing Screening Colonoscopy: What you should expect from your Endoscopist Anil K Sharma MD FACP Professor of Clinical Medicine, University of Rochester Chief of Gastroenterology,

More information

GIQIC18 Appropriate follow-up interval of not less than 5 years for colonoscopies with findings of 1-2 tubular adenomas < 10 mm

GIQIC18 Appropriate follow-up interval of not less than 5 years for colonoscopies with findings of 1-2 tubular adenomas < 10 mm GI Quality Improvement Consortium, Ltd. (GIQuIC) 1 Following is an overview of the clinical quality measures in GIQuIC that can be reported to CMS for the Quality performance category of the Merit-Based

More information

Colonoscopy Quality Data 2017

Colonoscopy Quality Data 2017 Colonoscopy Quality Data Introduction Colorectal cancer is the second leading cause of cancer related deaths in the United States, in men and women combined. According to the American Cancer Society, in

More information

Measure #425: Photodocumentation of Cecal Intubation National Quality Strategy Domain: Effective Clinical Care

Measure #425: Photodocumentation of Cecal Intubation National Quality Strategy Domain: Effective Clinical Care Measure #425: Photodocumentation of Cecal Intubation National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY DESCRIPTION: The rate of screening

More information

Measure #425: Photodocumentation of Cecal Intubation National Quality Strategy Domain: Effective Clinical Care

Measure #425: Photodocumentation of Cecal Intubation National Quality Strategy Domain: Effective Clinical Care Measure #425: Photodocumentation of Cecal Intubation National Quality Strategy Domain: Effective Clinical Care 2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Process DESCRIPTION: The

More information

With CRC Screening Rates on the Rise, Quality Control Becomes Center of Attention

With CRC Screening Rates on the Rise, Quality Control Becomes Center of Attention print this article In the News ISSUE: OCTOBER 2009 VOLUME: 60:10 With CRC Screening Rates on the Rise, Quality Control Becomes Center of Attention by Monica J. Smith New York In just the past year, New

More information

General and Colonoscopy Data Collection Form

General and Colonoscopy Data Collection Form Identifier: Sociodemographic Information Type: Zip Code: Inpatient Outpatient Birth Date: m m d d y y y y Gender: Height: (inches) Male Female Ethnicity: Weight: (pounds) African American White, Non-Hispanic

More information

GI Quality Improvement Consortium, Ltd. (GIQuIC) QCDR Non-PQRS Measure Specifications

GI Quality Improvement Consortium, Ltd. (GIQuIC) QCDR Non-PQRS Measure Specifications GI Quality Improvement Consortium, Ltd. (GIQuIC) 1 Following is an overview of the clinical quality measures in GIQuIC that can be reported to CMS for the Physician Quality Report System (PQRS) via GIQuIC

More information

An Updated Approach to Colon Cancer Screening and Prevention

An Updated Approach to Colon Cancer Screening and Prevention An Updated Approach to Colon Cancer Screening and Prevention Kevin Liebovich, MD Director for Quality for Gastrointestinal diseases Advocate Condell Medical Center Colon Cancer Screening and Prevention

More information

Merit-based Incentive Payment system (MIPS) 2018 Qualified Clinical Data Registry (QCDR) Measure Specifications

Merit-based Incentive Payment system (MIPS) 2018 Qualified Clinical Data Registry (QCDR) Measure Specifications Merit-based Incentive Payment system (MIPS) 2018 Qualified Clinical Data Registry (QCDR) Measure Specifications This document contains a listing of the clinical quality measures which the New Hampshire

More information

Technology and Interventions to Improve ADR

Technology and Interventions to Improve ADR Technology and Interventions to Improve ADR Aasma Shaukat, MD MPH, FACG GI Section Chief, Minneapolis VAMC Associate Professor, University of Minnesota Outline Why is quality important? Fundamentals of

More information

AMERICAN GASTROENTEROLOGICAL ASSOCIATION DIGESTIVE HEALTH RECOGNITION PROGRAM IN COLLABORATION WITH CECITY. Non-PQRS Narrative Measure Specifications

AMERICAN GASTROENTEROLOGICAL ASSOCIATION DIGESTIVE HEALTH RECOGNITION PROGRAM IN COLLABORATION WITH CECITY. Non-PQRS Narrative Measure Specifications AMERICAN GASTROENTEROLOGICAL ASSOCIATION DIGESTIVE HEALTH RECOGNITION PROGRAM IN COLLABORATION WITH CECITY Non-PQRS Narrative Measure Specifications 1 Table of Contents AGA DHRP CRC Measure #1: Colonoscopy

More information

Benchmarking For Colonoscopy. Technology and Technique to Improve Adenoma Detection

Benchmarking For Colonoscopy. Technology and Technique to Improve Adenoma Detection Benchmarking For Colonoscopy Technology and Technique to Improve Adenoma Detection Objectives 1. Review the latest data on performance characteristics and efficacy for colon cancer prevention 2. Highlight

More information

Quality Measures In Colonoscopy: Why Should I Care?

Quality Measures In Colonoscopy: Why Should I Care? Quality Measures In Colonoscopy: Why Should I Care? David Greenwald, MD, FASGE Professor of Clinical Medicine Albert Einstein College of Medicine Montefiore Medical Center Bronx, New York ACG/ASGE Best

More information

PQRS/QCDR/VBPM/GIQuIC -- Making $ense of All the Letters

PQRS/QCDR/VBPM/GIQuIC -- Making $ense of All the Letters Quality Measurement in GI 2015: PQRS/QCDR/VBPM/GIQuIC -- Making $ense of All the Letters January 24, 2015 Irving M. Pike, MD, FACG Irving.Pike_MD@JohnMuirHealth.com Who is Interested in Your Quality? You

More information

Tips to Improve ADRs during Colonoscopy

Tips to Improve ADRs during Colonoscopy Tips to Improve ADRs during Colonoscopy Aasma Shaukat, MD, MPH, FACG GI Section Chief, Minneapolis VAMC Associate Professor, University of Minnesota Outline Why is quality important? Fundamentals of high-quality

More information

Improving Access to Endoscopy at Safety-Net Hospitals. Lukejohn W. Day MD Assistant Professor of Medicine

Improving Access to Endoscopy at Safety-Net Hospitals. Lukejohn W. Day MD Assistant Professor of Medicine Improving Access to Endoscopy at Safety-Net Hospitals Lukejohn W. Day MD Assistant Professor of Medicine Goals Background Improving Access to Endoscopic Care Electronic referral: ereferral Direct Access

More information

Colon Screening in 2014 Offering Patients a Choice. Clark A Harrison MD The Nevada Colon Cancer Partnership

Colon Screening in 2014 Offering Patients a Choice. Clark A Harrison MD The Nevada Colon Cancer Partnership Colon Screening in 2014 Offering Patients a Choice Clark A Harrison MD The Nevada Colon Cancer Partnership Objectives 1. Understand the incidence and mortality rates for CRC in the US. 2. Understand risk

More information

Title Description Type / Priority

Title Description Type / Priority Merit-based Incentive Payment system (MIPS) 2019 Qualified Clinical Data Registry (QCDR) Measure Specifications Summary Listing of QCDR measures supported by the NHCR Measure # NHCR4 NHCR5 GIQIC12 GIQIC15

More information

MERIT-BASED INCENTIVE PAYMENT SYSTEM (MIPS) QUALITY CATEGORY

MERIT-BASED INCENTIVE PAYMENT SYSTEM (MIPS) QUALITY CATEGORY MERIT-BASED INCENTIVE PAYMENT SYSTEM (MIPS) QUALITY CATEGORY QUALITY PAYMENT PROGRAM FINAL RULE SUMMARY Synopsis For the Quality performance category, CMS finalized the proposal for greater reporting flexibility

More information

EXPERT WORKING GROUP Surveillance after neoplasia removal. Meeting Chicago, May 5th 2017 Chair: Rodrigo Jover Uri Ladabaum

EXPERT WORKING GROUP Surveillance after neoplasia removal. Meeting Chicago, May 5th 2017 Chair: Rodrigo Jover Uri Ladabaum EXPERT WORKING GROUP Surveillance after neoplasia removal Meeting Chicago, May 5th 2017 Chair: Rodrigo Jover Uri Ladabaum AIM To improve the quality of the evidences we have regarding post- polypectomy

More information

Improving Outcomes in Colorectal Cancer: The Science of Screening. Colorectal Cancer (CRC)

Improving Outcomes in Colorectal Cancer: The Science of Screening. Colorectal Cancer (CRC) Improving Outcomes in Colorectal Cancer: The Science of Screening Tennessee Primary Care Association October 23, 2014 Durado Brooks, MD, MPH Director, Prostate and Colorectal Cancers Colorectal Cancer

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Kaminski MF, Regula J, Kraszewska E, et al. Quality indicators

More information

WEO CRC SC Meeting. Barcelona, Spain October 23, 2015

WEO CRC SC Meeting. Barcelona, Spain October 23, 2015 WEO CRC SC Meeting Barcelona, Spain October 23, 2015 Identification of serrated polyposis syndrome in the context of population-based CRC screening programs Evelien Dekker Academic Medical Center Amsterdam,

More information

Colorectal Cancer Screening: Colonoscopy, Potential and Pitfalls. Disclosures: None. CRC: still a major public health problem

Colorectal Cancer Screening: Colonoscopy, Potential and Pitfalls. Disclosures: None. CRC: still a major public health problem Colorectal Cancer Screening: Colonoscopy, Potential and Pitfalls Disclosures: None Jonathan P. Terdiman, M.D. Professor of Clinical Medicine University of California, San Francisco CRC: still a major public

More information

Interval Cancers: What is Next?

Interval Cancers: What is Next? Interval Cancers: What is Next? Douglas Corley, MD, PhD Kaiser Permanente, Northern California Gastroenterologist, TPMG Director of Delivery Science & Applied Research Defining the mission Mercury project:

More information

August 21, National Quality Forum th St, NW Suite 800 Washington, D.C Re: Colonoscopy Quality Index (NQF# C 2056)

August 21, National Quality Forum th St, NW Suite 800 Washington, D.C Re: Colonoscopy Quality Index (NQF# C 2056) August 21, 2012 National Quality Forum 1030 15th St, NW Suite 800 Washington, D.C. 20005 Re: Colonoscopy Quality Index (NQF# C 2056) The American College of Gastroenterology (ACG), American Gastroenterological

More information

GI Screening/Surveillance in Lynch Syndrome

GI Screening/Surveillance in Lynch Syndrome GI Screening/Surveillance in Lynch Syndrome M Appleyard Royal Brisbane and Women s Hospital Brisbane, Australia GI Disease and Lynch Syndrome What are risks of GI disease in Lynch? Who do we screen for

More information

Screening for Colon Cancer: How best and how effective? Richard Rosenberg, MD Assistant Professor of Medicine Columbia University Medical Center

Screening for Colon Cancer: How best and how effective? Richard Rosenberg, MD Assistant Professor of Medicine Columbia University Medical Center Screening for Colon Cancer: How best and how effective? Richard Rosenberg, MD Assistant Professor of Medicine Columbia University Medical Center Colorectal Cancer Overview Joint Guideline: American Cancer

More information

Quality in Endoscopy: Can We Do Better?

Quality in Endoscopy: Can We Do Better? Quality in Endoscopy: Can We Do Better? Erik Rahimi, MD Assistant Professor Division of Gastroenterology, Hepatology, and Nutrition UT Health Science Center at Houston McGovern Medical School Ertan Digestive

More information

Improving the Adenoma Detection Rate. ADR is a (the) priority quality indicator

Improving the Adenoma Detection Rate. ADR is a (the) priority quality indicator Improving the Adenoma Detection Rate Douglas K. Rex, MD, MACG Indiana University School of Medicine Indianapolis, IN ADR is a (the) priority quality indicator Endorsed Adenoma Detection Rate Cecal intubation

More information

The New Grade A: USPSTF Updated Colorectal Cancer Screening Guidelines, What does it all mean?

The New Grade A: USPSTF Updated Colorectal Cancer Screening Guidelines, What does it all mean? The New Grade A: USPSTF Updated Colorectal Cancer Screening Guidelines, What does it all mean? Robert A. Smith, PhD Cancer Control, Department of Prevention and Early Detection American Cancer Society

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process Quality ID #185 (NQF 0659): Colonoscopy Interval for Patients with a History of Adenomatous Polyps Avoidance of Inappropriate Use National Quality Strategy Domain: Communication and Care Coordination 2018

More information

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Outcome High Priority

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Outcome High Priority Quality ID #343: Screening Colonoscopy Adenoma Detection Rate National Quality Strategy Domain: Effective Clinical Care Meaningful Measure Area: Preventive Care 2019 COLLECTION TYPE: MIPS CLINICAL QUALITY

More information

Retroflexion and prevention of right-sided colon cancer following colonoscopy: How I approach it

Retroflexion and prevention of right-sided colon cancer following colonoscopy: How I approach it Retroflexion and prevention of right-sided colon cancer following colonoscopy: How I approach it Douglas K Rex 1 MD, MACG 1. Indiana University School of Medicine Division of Gastroenterology/Hepatology

More information

Colorectal Cancer Screening

Colorectal Cancer Screening Colorectal Cancer Screening An Integrated Care Pathway of the Collaborative Care Network Subject Matter Expert: Kevin Wolov, DO Pathway Custodian: Pat Czapp, MD First, a Friendly Reminder... This Integrated

More information

2017 OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS ONLY. MEASURE TYPE: Process

2017 OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS ONLY. MEASURE TYPE: Process Measure. #185 (NQF 0659): Colonoscopy Interval for Patients with a History of Adenomatous Polyps Avoidance of Inappropriate Use National Quality Strategy Domain: Communication and Care Coordination 2017

More information

11/11/2015. Colon Cancer Screening in Underserved Communities The Road to 80% by Colonoscopic Findings. Eighty by Cancer Screening Rates

11/11/2015. Colon Cancer Screening in Underserved Communities The Road to 80% by Colonoscopic Findings. Eighty by Cancer Screening Rates Colonoscopic Findings Polyps Polyp encircled with wire loop and cut from wall using electrical current Post Polypectomy Colon Cancer Screening in Underserved Communities The Road to 80% by 2018 Suzanne

More information

GI Coding Updates. Rhonda Buckholtz, CPC, CPCI, CPMS, CRC, CDEO, CHPSE, CGSC, COBGC, CENTC, CPEDC

GI Coding Updates. Rhonda Buckholtz, CPC, CPCI, CPMS, CRC, CDEO, CHPSE, CGSC, COBGC, CENTC, CPEDC GI Coding Updates Rhonda Buckholtz, CPC, CPCI, CPMS, CRC, CDEO, CHPSE, CGSC, COBGC, CENTC, CPEDC Copyright/Disclaimer 2014 AAPC text CPT copyright 2016 American Medical Association. All rights reserved.

More information

Colorectal Cancer Screening in Ohio CHCs. Ohio Association of Community Health Centers

Colorectal Cancer Screening in Ohio CHCs. Ohio Association of Community Health Centers Colorectal Cancer Screening in Ohio CHCs Ohio Association of Community Health Centers 2 1/29/2015 Your Speakers Dr. Ted Wymyslo Ashley Ballard Randy Runyon 3 1/29/2015 Facts 3 rd most common cancer in

More information

FORTE: Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomas

FORTE: Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomas FORTE: Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomas CRC Screening is Increasing Up to date with recommended screening in U.S.: 54% in 2002 65% in 2010 80% goal for 2018 More people are getting

More information

Performance targets for lesion detection in surveillance

Performance targets for lesion detection in surveillance Performance targets for lesion detection in surveillance WEO CRC Meeting 2018, Washington DC Uri Ladabaum, M.D., M.S. Professor of Medicine; Director, GI Cancer Prevention Division of Gastroenterology

More information

Carol A. Burke, MD, FACG

Carol A. Burke, MD, FACG Updated Guidelines for CRC C Screening and Surveillance Carol A. Burke MD, FACG, FASGE, FACP Cleveland Clinic, Cleveland, OH Gastroenterology t 2012;143:844 143 Gut 2010;59:666 1 Caveat for all Recommendations

More information

Performance measures for lower gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative

Performance measures for lower gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative Performance measures for lower gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative Name: Institution: Michal F. Kaminski, MD, PhD Dept. of

More information

Measure #343: Screening Colonoscopy Adenoma Detection Rate National Quality Strategy Domain: Effective Clincal Care

Measure #343: Screening Colonoscopy Adenoma Detection Rate National Quality Strategy Domain: Effective Clincal Care Measure #343: Screening Colonoscopy Adenoma Detection Rate National Quality Strategy Domain: Effective Clincal Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY DESCRIPTION: The percentage

More information

Choice of sedation and its impact on adenoma detection rate in screening colonoscopies

Choice of sedation and its impact on adenoma detection rate in screening colonoscopies ORIGINAL ARTICLE Annals of Gastroenterology (2016) 29, 1-6 Choice of sedation and its impact on adenoma detection rate in screening colonoscopies Rahman Nakshabendi a, Andrew C. Berry b, Juan C. Munoz

More information

Learning and Earning with Gateway Professional Education CME/CEU Webinar Series

Learning and Earning with Gateway Professional Education CME/CEU Webinar Series Learning and Earning with Gateway Professional Education CME/CEU Webinar Series Best Practices for Colorectal Cancer Screening March 14, 2018 12:00pm 1:00pm Robert A. Smith, PhD Vice President, Cancer

More information

Prof Rupert Leong, Director of Endoscopy, Head of IBD Professor of Medicine UNSW, University of Sydney, Concord Hospital Australia IBDSydney

Prof Rupert Leong, Director of Endoscopy, Head of IBD Professor of Medicine UNSW, University of Sydney, Concord Hospital Australia IBDSydney 10:30-10:50 25 Sept 2017 Monday A-PSDE / WEO Colorectal Cancer Screening Committee (CRCSC) Meeting Room S228 (2/F) Prof Rupert Leong, Director of Endoscopy, Head of IBD Professor of Medicine UNSW, University

More information

The value of colonoscopy in isolated abdominal pain. Dr Aaditya Narendra, Dr Yi Ling Adeline Lim, Dr Casper Francois Pretorius

The value of colonoscopy in isolated abdominal pain. Dr Aaditya Narendra, Dr Yi Ling Adeline Lim, Dr Casper Francois Pretorius The value of colonoscopy in isolated abdominal pain Dr Aaditya Narendra, Dr Yi Ling Adeline Lim, Dr Casper Francois Pretorius Background Abdominal pain is a commonly reported symptom in the general population

More information

Colorectal Cancer Screening and Surveillance

Colorectal Cancer Screening and Surveillance 1 Colorectal Cancer Screening and Surveillance Jeffrey Lee MD, MAS Assistant Clinical Professor of Medicine University of California, San Francisco jeff.lee@ucsf.edu Objectives Review the various colorectal

More information

Research Article Development of Polyps and Cancer in Patients with a Negative Colonoscopy: A Follow-Up Study of More Than 20 Years

Research Article Development of Polyps and Cancer in Patients with a Negative Colonoscopy: A Follow-Up Study of More Than 20 Years ISRN Gastroenterology, Article ID 261302, 4 pages http://dx.doi.org/10.1155/2014/261302 Research Article Development of Polyps and Cancer in Patients with a Negative Colonoscopy: A Follow-Up Study of More

More information

Cost-effectiveness of colonoscopy in screening for colorectal cancer Sonnenberg A, Delco F, Inadomi J M

Cost-effectiveness of colonoscopy in screening for colorectal cancer Sonnenberg A, Delco F, Inadomi J M Cost-effectiveness of colonoscopy in screening for colorectal cancer Sonnenberg A, Delco F, Inadomi J M Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion

More information

Improving you ADR. Robert Enns Colonoscopy Education Day October 2018

Improving you ADR. Robert Enns Colonoscopy Education Day October 2018 Improving you ADR Robert Enns Colonoscopy Education Day October 2018 ADR Applying to CSP Assume 50% ADR in FIT positive patients Out of 40 patients only 20 will have polyps Out of 20 likely 15 will be

More information

Colorectal Cancer Screening: A Clinical Update

Colorectal Cancer Screening: A Clinical Update 11:05 11:45am Colorectal Cancer Screening: A Clinical Update SPEAKER Kevin A. Ghassemi, MD Presenter Disclosure Information The following relationships exist related to this presentation: Kevin A. Ghassemi,

More information

Achieving 80% by 2018: Working Together Can Get Us There. Zachary Gregg, MD Sentara Martha Jefferson April 18, 2016

Achieving 80% by 2018: Working Together Can Get Us There. Zachary Gregg, MD Sentara Martha Jefferson April 18, 2016 Achieving 80% by 2018: Working Together Can Get Us There Zachary Gregg, MD Sentara Martha Jefferson April 18, 2016 1 Prostate 21% Lung & bronchus 14% Colon & rectum 8% Urinary bladder 7% Melanoma of skin

More information

Quality ID #343: Screening Colonoscopy Adenoma Detection Rate National Quality Strategy Domain: Effective Clinical Care

Quality ID #343: Screening Colonoscopy Adenoma Detection Rate National Quality Strategy Domain: Effective Clinical Care Quality ID #343: Screening Colonoscopy Adenoma Detection Rate National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Outcome DESCRIPTION:

More information

Colorectal Cancer Screening: Cost-Effectiveness and Adverse events October, 2005

Colorectal Cancer Screening: Cost-Effectiveness and Adverse events October, 2005 Colorectal Cancer Screening: Cost-Effectiveness and Adverse events October, 2005 David Lieberman MD Chief, Division of Gastroenterology Oregon Health and Science University Portland VAMC Portland, Oregon

More information

Quality ID #439: Age Appropriate Screening Colonoscopy National Quality Strategy Domain: Efficiency and Cost Reduction

Quality ID #439: Age Appropriate Screening Colonoscopy National Quality Strategy Domain: Efficiency and Cost Reduction Quality ID #439: Age Appropriate Screening Colonoscopy National Quality Strategy Domain: Efficiency and Cost Reduction 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Efficiency DESCRIPTION:

More information

2. Describe pros/cons of screening interventions (including colonoscopy, CT colography, fecal tests)

2. Describe pros/cons of screening interventions (including colonoscopy, CT colography, fecal tests) Learning Objectives 1. Review principles of colon adenoma/cancer biology that permit successful prevention regimes 2. Describe pros/cons of screening interventions (including colonoscopy, CT colography,

More information

Improving Your Adenoma Detection Rate

Improving Your Adenoma Detection Rate Improving Your Adenoma Detection Rate JILL TINMOUTH, ASSOCIATE PROFESSOR, UNIVERSITY OF TORONTO JERRY MCGRATH, ASSOCIATE PROFESSOR, MEMORIAL UNIVERSITY OF NEWFOUNDLAND FEB. 11 2017 X CanMEDS Roles Covered

More information

Dr Alasdair Patrick Gastroenterologist

Dr Alasdair Patrick Gastroenterologist Dr Alasdair Patrick Gastroenterologist Bowel Cancer screening Dr Alasdair Patrick Gastroenterologist MacMurray Gastroenterology Case- Patient for Screening? 62 year old lady Father diagnosed with advanced

More information

Copyright McMahon 2014

Copyright McMahon 2014 the Science Behind Positive Patient Outcomes Brought to you by Supported by December 2014 The Role of Technology in Optimizing Colonoscopy Quality and Efficiency Faculty Seth A. Gross, MD, FACG Chair Assistant

More information

The Use of Quality Measures in Colorectal Cancer Screening

The Use of Quality Measures in Colorectal Cancer Screening The Use of Quality Measures in Colorectal Cancer Screening Susan Hutfless PhD Johns Hopkins University School of Medicine, Division of Gastroenterology & Johns Hopkins Bloomberg School of Public Health,

More information

Is the level of cleanliness using segmental Boston bowel preparation scale associated with a higher adenoma detection rate?

Is the level of cleanliness using segmental Boston bowel preparation scale associated with a higher adenoma detection rate? ORIGINAL ARTICLE Annals of Gastroenterology (208) 3, 27-223 Is the level of cleanliness using segmental Boston bowel preparation scale associated with a higher adenoma detection rate? Abimbola Adike a,

More information

Alberta Colorectal Cancer Screening Program (ACRCSP) Post Polypectomy Surveillance Guidelines

Alberta Colorectal Cancer Screening Program (ACRCSP) Post Polypectomy Surveillance Guidelines Alberta Colorectal Cancer Screening Program (ACRCSP) Post Polypectomy Surveillance Guidelines June 2013 ACRCSP Post Polypectomy Surveillance Guidelines - 2 TABLE OF CONTENTS Background... 3 Terms, Definitions

More information

Quality in Endoscopy and Cost Effective Practice

Quality in Endoscopy and Cost Effective Practice Quality in Endoscopy and Cost Effective Practice Sunanda Kane, MD MSPH FACG Director, ACG Quality Council 1 What is Quality and/or Cost Effectiveness in an Endoscopic Practice? Value Equation Quality (Outcomes,

More information

Polyp detection rates as quality indicator in clinical versus screening colonoscopy

Polyp detection rates as quality indicator in clinical versus screening colonoscopy Polyp detection rates as quality indicator in clinical versus screening colonoscopy Authors G. Hoff 1, 2, 3,E.Botteri 2,O.Høie 4,K.Garborg 3, 5,H.Wiig 6,G.Huppertz-Hauss 7,V.Moritz 7, M. Bretthauer 3,

More information

Objectives. Definitions. Colorectal Cancer Screening 5/8/2018. Payam Afshar, MS, MD Kaiser Permanente, San Diego. Colorectal cancer background

Objectives. Definitions. Colorectal Cancer Screening 5/8/2018. Payam Afshar, MS, MD Kaiser Permanente, San Diego. Colorectal cancer background Colorectal Cancer Screening Payam Afshar, MS, MD Kaiser Permanente, San Diego Objectives Colorectal cancer background Colorectal cancer screening populations Colorectal cancer screening modalities Colonoscopy

More information

Finding and Removing Difficult Polyps (safely)

Finding and Removing Difficult Polyps (safely) Finding and Removing Difficult Polyps (safely) David Lieberman MD Chief, Division of Gastroenterology and Hepatology Oregon Health and Science University Colonoscopy Clouds Interval Cancers Interval Cancer:

More information

Interview with Prof. Guido Costamagna

Interview with Prof. Guido Costamagna Interview with Prof. Guido Costamagna Extraxts of his curriculum vitae: Full Professor of Surgery, Università Cattolica del Sacro Cuore, Rome, Italy Director, Digestive Endoscopy Unit, Policlinico A. Gemelli,

More information

CRC Risk Factors. U.S. Adherence Rates Cancer Screening. Genetic Model of Colorectal Cancer. Epidemiology and Clinical Consequences of CRC

CRC Risk Factors. U.S. Adherence Rates Cancer Screening. Genetic Model of Colorectal Cancer. Epidemiology and Clinical Consequences of CRC 10:45 11:45 am Guide to Colorectal Cancer Screening SPEAKER Howard Manten M.D. Presenter Disclosure Information The following relationships exist related to this presentation: Howard Manten MD: No financial

More information

Supporting Information 2. ESGE QIC Lower GI Delphi voting process: Round 1 Working Group chair: Michal F. Kaminski, Poland

Supporting Information 2. ESGE QIC Lower GI Delphi voting process: Round 1 Working Group chair: Michal F. Kaminski, Poland Supporting Information 2. ESGE QIC Lower GI Delphi voting process: Round 1 Working chair: Michal F. Kaminski, Poland Population Interventions Comparator Outcome Additional evidence 1.1 Rate of adequate

More information

Colon Cancer Screening and Surveillance. Louis V. Antignano, M.D. Wilson Gastroenterology October 11, 2011

Colon Cancer Screening and Surveillance. Louis V. Antignano, M.D. Wilson Gastroenterology October 11, 2011 Colon Cancer Screening and Surveillance Louis V. Antignano, M.D. Wilson Gastroenterology October 11, 2011 Colorectal Cancer Preventable cancer Number 2 cancer killer in the USA Often curable if detected

More information

Colorectal Cancer: Screening & Surveillance

Colorectal Cancer: Screening & Surveillance Objectives Colorectal Cancer: Screening & Surveillance Chanda K. Ho, MD MPH Advances in Internal Medicine Brief overview epidemiology and pathogenesis of colorectal cancer (CRC) To review screening modalities

More information

THE EFFECT OF PUBLIC AND PHYSICIAN EDUCATION ON COMMUNITY COLORECTAL CANCER SCREENING. Michael D Sarap MD, FACS Ohio CoC Co Chair

THE EFFECT OF PUBLIC AND PHYSICIAN EDUCATION ON COMMUNITY COLORECTAL CANCER SCREENING. Michael D Sarap MD, FACS Ohio CoC Co Chair THE EFFECT OF PUBLIC AND PHYSICIAN EDUCATION ON COMMUNITY COLORECTAL CANCER SCREENING Michael D Sarap MD, FACS Ohio CoC Co Chair Disclosures None Colon Cancer in Ohio ~6,600 Ohioans will be diagnosed with

More information

American Gastroenterological Association (AGA) Colorectal Cancer (CRC) Screening and Surveillance Measures January 1, 2015 to December 31, 2015

American Gastroenterological Association (AGA) Colorectal Cancer (CRC) Screening and Surveillance Measures January 1, 2015 to December 31, 2015 2015 PQRS MEASURES F COLECTAL CANCER SCREENING QCDR: DHRP #1: DHRP #2: Colonoscopy Interval for Patients with a History of Adenomatous Polyps Avoidance of Inappropriate Use National Quality Strategy Domain:

More information

2/14/2018 CODING PITFALLS IN THE ASC AVERAGE RISK VS HIGH RISK SCREENING TOP CODING PITFALLS

2/14/2018 CODING PITFALLS IN THE ASC AVERAGE RISK VS HIGH RISK SCREENING TOP CODING PITFALLS CODING PITFALLS IN THE ASC Presented by: Kristin Vaughn, CPC, CGCS, CPMA, ICDCT-CM Healthcare Consultant and Lead Auditor AskMueller Consulting, LLC Kristin@askmuellerconsulting.com TOP CODING PITFALLS

More information

Colon Polyps: Detection, Inspection and Characteristics

Colon Polyps: Detection, Inspection and Characteristics Colon Polyps: Detection, Inspection and Characteristics Stephen Kim, M.D. Assistant Professor of Medicine Interventional Endoscopy Services UCLA Division of Digestive Diseases September 29, 2018 1 Disclosures

More information

Research Article Postcolonoscopy Followup Recommendations: Comparison with and without Use of Polyp Pathology

Research Article Postcolonoscopy Followup Recommendations: Comparison with and without Use of Polyp Pathology Diagnostic and erapeutic Endoscopy, Article ID 683491, 7 pages http://dx.doi.org/10.1155/2014/683491 Research Article Postcolonoscopy Followup Recommendations: Comparison with and without Use of Polyp

More information

7/11/2017 ICD 10 AND MIPS: THE KEY TO ECONOMIC SURVIVAL DIAGNOSIS CODING WITH SPECIFICITY CLINICAL EXAMPLES: SPECIFICITY IS KEY

7/11/2017 ICD 10 AND MIPS: THE KEY TO ECONOMIC SURVIVAL DIAGNOSIS CODING WITH SPECIFICITY CLINICAL EXAMPLES: SPECIFICITY IS KEY ICD 10 AND MIPS: THE KEY TO ECONOMIC SURVIVAL Presented by: Kristin Vaughn, CPC, CGCS, CPMA, ICDCT-CM Healthcare Consultant and Lead Auditor AskMueller Consulting, LLC Kristin@askmuellerconsulting.com

More information

Colon Cancer Screening. Layth Al-Jashaami, MD GI Fellow, PGY 4

Colon Cancer Screening. Layth Al-Jashaami, MD GI Fellow, PGY 4 Colon Cancer Screening Layth Al-Jashaami, MD GI Fellow, PGY 4 -Colorectal cancer (CRC) is a common and lethal cancer. -It has the highest incidence among GI cancers in the US, estimated to be newly diagnosed

More information

Screening & Surveillance Guidelines

Screening & Surveillance Guidelines Chapter 2 Screening & Surveillance Guidelines I. Eligibility Coloradans ages 50 and older (average risk) or under 50 at elevated risk for colon cancer (personal or family history) that meet the following

More information

Is there justification for levels of polyp competency? Dr Roland Valori Gloucestershire Hospitals United Kingdom

Is there justification for levels of polyp competency? Dr Roland Valori Gloucestershire Hospitals United Kingdom Is there justification for levels of polyp competency? Dr Roland Valori Gloucestershire Hospitals United Kingdom What exactly will be required? Defining levels of polypectomy competency in terms of complexity/time/risk

More information

Colonoscopy overuse in colorectal cancer screening in Argentina. Ignacio Ricci

Colonoscopy overuse in colorectal cancer screening in Argentina. Ignacio Ricci Colonoscopy overuse in colorectal cancer screening in Argentina Ignacio Ricci What? International guidelines overall agree on starting colorectal cancer screening at age 50 for both women and men. If colonoscopy

More information

6 semanas de embarazo. Tubulovillous adenoma with dysplasia icd 10. Inicio / Embarazo / 6 semanas de embarazo

6 semanas de embarazo. Tubulovillous adenoma with dysplasia icd 10. Inicio / Embarazo / 6 semanas de embarazo Inicio / Embarazo / 6 semanas de embarazo 6 semanas de embarazo Tubulovillous adenoma with dysplasia icd 10 Free, official coding info for 2018 ICD-10-CM D13.2 - includes detailed rules, notes, synonyms,

More information

Hamideh Salimzadeh, PhD Assistant Professor, Digestive Diseases Research Center,Tehran University of Medical Sciences, Shariati Hospital, North

Hamideh Salimzadeh, PhD Assistant Professor, Digestive Diseases Research Center,Tehran University of Medical Sciences, Shariati Hospital, North Hamideh Salimzadeh, PhD Assistant Professor, Digestive Diseases Research Center,Tehran University of Medical Sciences, Shariati Hospital, North Kargar Avenue 14666 Tehran, Iran. Tel: +98-21-82415415 Fax:

More information

removal of adenomatous polyps detects important effectively as follow-up colonoscopy after both constitute a low-risk Patients with 1 or 2

removal of adenomatous polyps detects important effectively as follow-up colonoscopy after both constitute a low-risk Patients with 1 or 2 Supplementary Table 1. Study Characteristics Author, yr Design Winawer et al., 6 1993 National Polyp Study Jorgensen et al., 9 1995 Funen Adenoma Follow-up Study USA Multi-center, RCT for timing of surveillance

More information

Quality Outcomes for Endoscopy

Quality Outcomes for Endoscopy Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/gi-insights/quality-outcomes-for-endoscopy/3744/

More information

Do any benign polyps require an operation?

Do any benign polyps require an operation? Do any benign polyps require an operation? Kevin Waschke MD.,CM., FRCPC, FASGE McGill University Health Center President Elect Canadian Association of Gastroenterology Colonoscopy Education Day - Tuesday

More information

Dysplasia 4/19/2017. How do I practice Chromoendoscopy for Surveillance of Colitis? SCENIC: Polypoid Dysplasia in UC. Background

Dysplasia 4/19/2017. How do I practice Chromoendoscopy for Surveillance of Colitis? SCENIC: Polypoid Dysplasia in UC. Background SCENIC: Polypoid in UC Definition How do I practice for Surveillance of Colitis? Themos Dassopoulos, M.D. Director, BSW Center for IBD Themistocles.Dassopoulos@BSWHealth.org Tel: 469-800-7189 Cell: 314-686-2623

More information

Capsule endoscopy screening. Carlo SENORE

Capsule endoscopy screening. Carlo SENORE Capsule endoscopy screening Carlo SENORE Possible conflicts of interest Medtronics provides CCE-2 devices to conduct a multicenter independent, non profit study, aimed to assess CCE-2 diagnostic accuracy

More information

Increasing Colorectal Cancer Screening in Wyoming. Allie Bain, MPH Outreach & Education Supervisor Wyoming Integrated Cancer Services Program

Increasing Colorectal Cancer Screening in Wyoming. Allie Bain, MPH Outreach & Education Supervisor Wyoming Integrated Cancer Services Program Increasing Colorectal Cancer Screening in Wyoming Allie Bain, MPH Outreach & Education Supervisor Wyoming Integrated Cancer Services Program Overview What is colorectal cancer? What are risk factors for

More information

Latest Endoscopic Guidelines for FAP, HNPCC, IBD, and the General Population

Latest Endoscopic Guidelines for FAP, HNPCC, IBD, and the General Population Latest Endoscopic Guidelines for FAP, HNPCC, IBD, and the General Population David T. Rubin, M.D. Assistant Professor of Medicine Inflammatory Bowel Disease Center MacLean Center for Clinical Medical Ethics

More information

National Colonoscopy Study (NCS) Screening Colonoscopy versus Annual Fecal Occult Blood Test NCT

National Colonoscopy Study (NCS) Screening Colonoscopy versus Annual Fecal Occult Blood Test NCT National Colonoscopy Study (NCS) Screening Colonoscopy versus Annual Fecal Occult Blood Test NCT 00102011 Ann Zauber Sidney Winawer, Michael O Brien, John Allen, Andrew Feld, Glenn Mills, Robin Mendelsohn,

More information

EDWARD J. SHARE, M.D. COLONOSCOPY SCREENING

EDWARD J. SHARE, M.D. COLONOSCOPY SCREENING EDWARD J. SHARE, M.D. CEDARS-SINAI MEDICAL OFFICE TOWERS 8631 W. THIRD ST. SUITE 1015E LOS ANGELES, CALIFORNIA 90048 PHONE 310-652-4472 FAX 310-358-2266 GASTROENTEROLOGY AND HEPATOLOGY COLONOSCOPY SCREENING

More information

The National Guidelines For Colorectal Cancer Screening and Diagnosis.

The National Guidelines For Colorectal Cancer Screening and Diagnosis. The National Guidelines For Colorectal Cancer Screening and Diagnosis www.mohap.gov.ae December, 2014 Adapted from HAAD Standard for Colorectal Cancer Screening & Diagnosis 2014 The National Cancer Screening

More information

Missed Lesions at Endoscopy. Dr Russell Walmsley, MD, FRCP, FRACP Gastroenterologist WDHB Chair Endoscopy Guidance Group for New Zealand

Missed Lesions at Endoscopy. Dr Russell Walmsley, MD, FRCP, FRACP Gastroenterologist WDHB Chair Endoscopy Guidance Group for New Zealand Missed Lesions at Endoscopy Dr Russell Walmsley, MD, FRCP, FRACP Gastroenterologist WDHB Chair Endoscopy Guidance Group for New Zealand Missed Lesions at Endoscopy Is there a problem? With Gastroscopy

More information